Name: UMIN ID:
Unique ID issued by UMIN | UMIN000003483 |
---|---|
Receipt number | R000004216 |
Scientific Title | Phase II study of biweekly cetuximab and irinotecan for unresectable advanced/recurrent colorectal cancer. Phoenix study |
Date of disclosure of the study information | 2010/04/14 |
Last modified on | 2010/05/11 01:29:33 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2010/04/13 11:58:57 | ||
2 | Update | 2010/05/11 01:29:33 | Last name of lead principal investigator |